| Drug Type Small molecule drug | 
| Synonyms | 
| Target | 
| Action inhibitors | 
| Mechanism CEN inhibitors(cap-dependent endonuclease inhibitors) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 
| Molecular FormulaC24H21F2N3O7S | 
| InChIKeyDSVWCMHWKYQETQ-UXHICEINSA-N | 
| CAS Registry3049173-52-3 | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Influenza A virus infection | Preclinical | China  | 10 Dec 2024 | |
| Influenza B virus infection | Preclinical | China  | 10 Dec 2024 | 





